Clinical and immunological assessment of a candidate Lyme disease vaccine in healthy adults: Antibody persistence and effect of a booster dose at month 12

Vaccine

Volumn 16, Issue 17, 1998, Pages 1688-1692

  Van Hoecke, C ^a   Fu, D ^a   De Grave, D ^a   Voet, P ^a   Lebacq, E ^b  

^a GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^b Clinique Notre Dame de Grace   (Belgium)

Author keywords

Bactericidal antibodies; Lyme disease; Vaccine

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL VACCINE; BACTERIUM ANTIBODY; LIPOPROTEIN; OUTER MEMBRANE PROTEIN;

ADULT; ANTIBODY RESPONSE; ARTICLE; BACTERICIDAL ACTIVITY; BORRELIA BURGDORFERI; CLINICAL TRIAL; DOSE RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; IMMUNOGENICITY; INJECTION PAIN; INTRAMUSCULAR DRUG ADMINISTRATION; LYME DISEASE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SKIN MANIFESTATION; VACCINATION;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; ANTIGENS, SURFACE; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; BLOOD BACTERICIDAL ACTIVITY; BORRELIA BURGDORFERI GROUP; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; LIPOPROTEINS; MALE; MIDDLE AGED;

EID: 0032192586     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00052-8     Document Type: Article

References (18)

1. 1 Burgdorfer, W. Discovery of the Lyme disease spirochete and its relation to tick vectors. Yale J. Biol. Med. 1984, 57, 515-520.
2. 2 Barfour, A.G. Isolation and cultivation of Lyme disease spirochetes. Yale J. Biol. Med. 1984, 57, 521-525.
3. 3 Steere, A.C., Grodzicki, R.L. and Kornblatt, A.N. et al. The spirochetal etiology of Lyme disease. N. Engl. J. Med. 1983, 308, 733-740.
4. 4 Wright, D. Lyme disease: the American divide. Lancet 1994, 344, 52.
5. 5 Johnson, R.C., Kodner, C. and Russell, M. Passive immunization of hamsters against experimental infection with B. burgdorferi. Infect. Immun. 1986, 53, 713-716.
6. 6 Johnson, R.C., Kodner, C., Russell, M. and Duray, P.H. Active immunization of hamsters against experimental infection with B. burgdorferi. Infect. Immun. 1986, 54, 897-899.
7. 7 Schaible, U.E., Kramer, M.D., Eichmann, K., Modolell, M., Museteanu, C. and Simon, M.M. Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immuno-deficiency (scid) mice. Proc. Natl Acad. Sci. USA 1990, 87, 3768-3772.
8. 8 Simon, M.M., Schaible, U.E. and Kramer, M.D. et al. Recombinant OspA from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice. J. Infect. Dis. 1991, 164, 123-132.
9. 9 Telford, S.R. III Jr., Cantor, F.S. and Lobe, Y. et al. Efficacy of human lyme disease vaccine formulations in a mouse model. J. Infect. Dis. 1995, 171, 1368-1370.
10. 10 Wormser, G.P. Prospects for a vaccine to prevent Lyme Disease in humans. Clin. Infect. Dis. 1995, 21, 1267-1274.
11. 11 Telford, S.R. Jr. III and Fikrig, E. Progress towards a vaccine for Lyme disease. Clin. Immunother. 1995, 4, 49-60.
12. 12 Golde, W.T., Burkot, T.R. and Piesman, J. et al. The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi. Vaccine 1995, 13, 435-441.
13. 13 Keller, D., Koster, F.T., Marks, D.H., Hosbach, P., Erdile, L.F. and Mays, J.P. Safety and immunogenicity of a recombinant outer surface protein A Lyme vaccine. JAMA 1994, 271, 1764-1768.
14. 14 Van Hoecke, C., Comberbach, M. and De Grave, D. et al. Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adults. Vaccine 1996, 14, 1620-1626.
15. 15 Karpinski, K.F., Hayward, S. and Trphonas, H. Statistical considerations in the quantitation of serum immunoglobulin levels using the enzyme linked immunosorbent assay (ELISA). J. Immun. Meth. 1987, 103, 189-194.
16. 16 Aydintug, M.K., Gu, Y. and Philipp, M. Borrelia burgdorferi antigens that are targeted by antibody-dependent, complement-mediated killing in the rhesus monkey. Infect Immun. 1994, 62, 4929-4937.
17. 17 Calister, S.M., Schell, R.F. and Lovrich, S.D. Lyme Disease Assay which detects killed Borrelia burgdorferi. J. Clin. Microbiol. 1991, 29, 1773-1776.
18. 18 Paddilla, M.L., Callister, S.M. and Schell, R.F. et al. Characterization of the protective borrecidal antibody response in humans and hamsters after vaccination with a Borellia burgdorferi outer surface protein A vaccine. J. Infect Dis. 1996, 174, 739-746.